# Study to Evaluate the Effect of HT-4253 for the Prevention of Alzheimer's Disease in APOE4 Carriers

> clinical trial · VERIFIED · 2026-08-05

Status: RECRUITING · Sponsor: Halia Therapeutics, Inc. · Condition: Alzheimers Disease

- Company: Halia Therapeutics, Inc.
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07399171

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.